Nurix Therapeutics Cash Flow Statement (2019-2026) | NRIX

Cash Flow Statement Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025 Feb2026 May2026
Operating Activities
Net Income (Quarter)
-28.86M-37.69M-42.53M-45.40M-45.71M-46.72M-40.73M-24.28M-36.98M-41.96M-41.52M-44.55M-48.96M-58.55M-56.35M-43.46M-86.42M-78.22M-87.95M-89.53M
Share-based Compensation (Quarter)
2.21M4.84M6.07M68.20M85.90M28.13M0.02M0.02M0.03M33.60M7.82M8.85M-15.37M32.63M8.72M10.38M9.77M-28.86M2.72M18.07M
Cash from Operations (Quarter)
-29.97M-30.91M-42.63M-32.91M-46.31M-37.95M-48.45M-18.47M-41.13M26.69M-41.95M-39.70M-42.18M-48.75M-61.09M-63.16M-57.38M-67.83M-71.91M-96.57M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.53M-0.61M-0.54M-0.45M-0.08M0.65M0.82M0.99M1.65M1.97M1.93M2.16M3.71M3.49M3.56M2.70M2.20M1.87M1.98M1.56M
Amortization of Deferred Charges (Quarter)
0.86M0.85M1.26M1.35M1.43M1.42M1.43M1.44M1.43M1.82M1.84M1.76M1.75M1.75M1.78M2.85M2.97M2.51M1.58M1.59M
Depreciation & Amortization (CF) (Quarter)
0.70M0.79M0.99M1.30M1.50M1.57M1.75M1.90M1.95M1.90M2.04M2.33M2.39M2.55M2.35M2.24M2.03M2.08M2.20M2.25M
Change in Working Capital
Change in Receivables (Quarter)
2.00M-2.00M
Change in Account Payables (Quarter)
-1.39M0.86M-0.10M1.85M-0.76M-0.90M0.40M-2.24M-1.20M4.65M-0.93M-2.54M1.09M7.58M-3.21M-2.68M2.23M3.02M-0.46M1.87M
Change in Accured Expenses (Quarter)
3.53M3.38M-3.32M6.14M1.36M3.30M-6.91M2.26M4.70M3.08M3.59M-6.84M6.04M9.02M6.94M-7.01M6.34M11.04M4.12M-15.25M
Other Working Capital Changes (Quarter)
5.20M-0.60M1.51M0.00M0.73M-1.16M1.63M-2.14M-2.04M0.42M-1.17M-0.17M0.57M1.23M6.25M-3.29M1.98M1.28M-1.29M-0.26M
Investing Activities
Capital Expenditures (Quarter)
4.19M0.86M3.47M-0.78M6.99M2.56M2.28M1.08M2.46M-5.18M0.85M1.08M5.24M-5.53M3.48M-2.40M1.04M-0.94M1.70M1.28M
Change in Acquisitions & Divestments (Quarter)
64.21M55.02M58.75M62.81M72.77M84.48M40.99M105.62M99.82M76.61M93.20M95.98M110.83M159.50M139.20M142.34M156.19M179.81M133.15M119.56M
Cash from Investing Activities (Quarter)
-12.23M-36.52M40.03M-4.76M-63.08M55.01M16.07M43.83M22.77M-14.37M35.51M-131.07M-21.34M-140.82M25.53M71.50M50.48M0.35M-123.83M93.00M
Financing Activities
Other financing activities (Quarter)
0.12M-1.17M1.06M-92.99M1.45M-1.40M2.18M0.35M0.91M2.34M-1.47M0.22M0.01M2.00M0.38M1.22M
Cash from Financing Activities (Quarter)
1.55M0.50M1.49M0.43M115.41M-0.14M1.48M0.03M1.70M0.01M1.62M237.75M45.77M200.52M1.47M0.01M1.16M236.01M19.98M0.07M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
50.20M42.90M95.40M18.00M
Additional items
Change in Cash (Quarter)
-40.65M-66.93M-1.11M-37.25M6.02M16.92M-30.90M25.39M-16.65M12.32M-4.81M66.98M-17.75M10.95M-34.08M8.34M-5.75M168.52M-175.76M-3.51M
Free Cash Flow (Quarter)
-34.16M-31.77M-46.10M-32.13M-53.29M-40.52M-50.73M-19.55M-43.59M31.87M-42.81M-40.78M-47.41M-43.23M-64.57M-60.76M-58.42M-66.89M-73.61M-97.85M
Net Cash Flow (Quarter)
-40.65M-66.93M-1.11M-37.25M6.02M16.92M-30.90M25.39M-16.65M12.32M-4.81M66.98M-17.75M10.95M-34.08M8.34M-5.75M168.52M-175.76M-3.51M